Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
Authors:
- M Kay GarciaMGM Kay Garcia
- Lorenzo CohenLCLorenzo Cohen
- Ying GuoYGYing Guo
- Yuhong ZhouYZYuhong Zhou
- Bing YouBYBing You
- Joseph ChiangJCJoseph Chiang
- Robert Z OrlowskiRORobert Z Orlowski
- Donna WeberDWDonna Weber
- Jatin ShahJSJatin Shah
- Raymond AlexanianRARaymond Alexanian
- Sheeba ThomasSTSheeba Thomas
- Jorge RomagueraJRJorge Romaguera
Open Access
- 9 May 2014
- journal article
- research article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 7 (1) , 41
Abstract
This single-arm study evaluated feasibility, safety, and initial efficacy of electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy (PN) in cancer patients with multiple myeloma. Patients with neuropathy ≥ grade 2 received 20 acupuncture treatments over 9 weeks. For the 19 evaluable patients, Functional Assessment of Cancer Therapy/Gynecological Oncology Group-Neurotoxicity (FACT/GOG/NTX) mean (SD) scores improved significantly between baseline and week 13 (20.8 [9.6] vs 13.2 [8.5], p = 0.0002). Moderate effect size differences began on week 4, with the largest effect size differences found at week 9 for FACT/GOG/NTX scores, worst pain in the last 24 hours, and pain severity (Cohen’s d = 1.43, 1.19, and 1.08, respectively) and continuing through week 13 (Cohen’s d = 0.86, 0.88, and 0.90, respectively). From baseline to week 13, additional significant improvements were seen as follows: postural stability (1.0 [0.6] vs 0.8 [0.4], p = 0.02); coin test (10.0 [7.4] vs 5.6 [1.9], p < 0.0001); button test (96.1 [144.4] vs 54.9 [47.3], p < 0.0001); and walking test (21.6 [10.0] vs 17.2 [7.7], p = 0.0003). No significant changes were seen with NCS. Acupuncture may help patients experiencing thalidomide- or bortezomib-induced PN. Larger, randomized, clinical trials are needed. ClinicalTrials.gov Identifier: NCT00891618 .Keywords
This publication has 37 references indexed in Scilit:
- Management of treatment-emergent peripheral neuropathy in multiple myelomaLeukemia, 2011
- Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healingPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
- Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaBlood, 2010
- Fifteen-day Acupuncture Treatment Relieves Diabetic Peripheral NeuropathyJournal of Acupuncture and Meridian Studies, 2010
- Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literatureBlood, 2008
- Neural mechanism underlying acupuncture analgesiaProgress in Neurobiology, 2008
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndromeBMJ, 2008
- Aortoduodenal fistula complicated by acupunctureInternational Journal of Cardiology, 2005
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Rare but Serious Complications of Acupuncture: Traumatic LesionsAcupuncture in Medicine, 2001